View source for China Reports Progress In Swine Fever Vaccine Trials

A widespread outbreak of swine fever wiped out about 40 percent of China's pig herd<br>  <br>A vaccine developed in China for African swine fever, which devastated the country's pig herd and caused pork prices to soar, is progressing smoothly, according to results reported on Wednesday.<br> <br>The widespread outbreak of swine fever since August 2018 has disrupted the supply of pork in China, where it is a staple meat, with millions of animals culled.<br> <br>The disease wiped out about 40 percent of the country's pig herd, causing prices to rocket as officials struggled to stabilise supplies.<br> <br>Authorities have since been looking into means of preventing the disease, and the vaccine strain passed a national review in December 2019, according to a report by the China Science Daily posted on the website of the Chinese Academy of Agricultural Sciences (CAAS).<br> <br>In March, the [http://www.ajaxtime.com/?s=vaccine vaccine] was approved by the agriculture ministry for clinical trials in northern Heilongjiang province, central Henan province and northwest Xinjiang region.<br> <br>Clinical trials of the vaccine developed by the Harbin Veterinary Research [http://www.google.com/search?q=Institute&btnI=lucky Institute] were seeing "smooth progress", according to the CAAS.<br> <br>About 3,000 pigs are involved in the ongoing trials, launched between April and June, with the animals in "good condition", said the report.<br> <br>Vaccinated sows have not shown abnormal clinical conditions or miscarriages, and  [https://www.kynghidongduong.vn/tours/tour-trung-quoc-huu-nghi-quan-nam-ninh-que-lam-4-ngay.html kynghidongduong.vn] the pigs have not made any toxic discharge of the vaccine.<br> <br>Since immunisation, the fatality rate has been under one percent,  [https://www.kynghidongduong.vn/tours/tour-trung-quoc-huu-nghi-quan-nam-ninh-que-lam-4-ngay.html tour du lịch quế lâm] and the immunised herd has not shown significant differences to the control group.<br> <br>The CAAS is expected to "accelerate the development of the vaccine" in the next step.<br>